Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Fennec Pharmaceuticals Inc. publishes a filing, an earnings call transcript or a press release.

Get FENC alerts

About Robert Andrade

Robert Andrade is recorded as CFO at Fennec Pharmaceuticals Inc. (FENC). The proxy statement of Fennec Pharmaceuticals Inc. reports total compensation of $1,158,858 for Robert Andrade in fiscal 2020, including a base salary of $311,750. Disclosed compensation is on record for 3 fiscal years. Robert Andrade has spoken on 12 earnings calls and 4 other investor events across 1 company, most recently for Fennec Pharmaceuticals Inc. on September 15, 2026. Fennec Pharmaceuticals Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Fennec Pharmaceuticals Inc. includes Adrian Haigh (COO), Jeff Hackman (Board Member) and Jeffrey S. Hackman (Board Member).

Robert Andrade on recent calls

“This is maybe going on 10 years for us, so much appreciated. it, and I see some new faces and some existing faces that have been interested in the story. So this is our safe harbor statement.”
CFO, H.C. WAINWRIGHT 28TH ANNUAL GLOBAL INVESTMENT CONFERENCE ·
“This is maybe going on 10 years for us, so much appreciated. it, and I see some new faces and some existing faces that have been interested in the story. So this is our safe harbor statement.”
CFO, H.C. Wainwright 28th Annual Global Investment Conference ·
“We would like to thank you for joining us. We are pleased to host Fennec Pharmaceuticals' second quarter 2026 earnings conference call today, during which we will review our financial results as well as provide a general business update.”
CFO, Fennec Pharmaceuticals Q2 2026 Conference Call ·
“Yeah, so important to note, since Jeff joined, we have nearly doubled our quarterly revenue. So when Jeff joined, we were around $7 million, flatlined, predominantly all pediatric.”
CFO, H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ ·
“Yeah, so important to note, since Jeff joined, we have nearly doubled our quarterly revenue. So when Jeff joined, we were around $7 million, flatlined, predominantly all pediatric.”
CFO, H.C. WAINWRIGHT 4TH ANNUAL BIOCONNECT INVESTOR CONFERENCE AT NASDAQ ·

Affiliation history

Company network

Leadership on record at Fennec Pharmaceuticals Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2020 Fennec Pharmaceuticals Inc. (FENC) $311,750 $1,158,858
2019 Fennec Pharmaceuticals Inc. (FENC) $325,211 $863,766
2018 Fennec Pharmaceuticals Inc. (FENC) $250,000 $669,099

Recent activity

Show 4 earlier activities